BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34935837)

  • 1. Cholesterol-lowering effect of bile salt hydrolase from a
    Zhu H; Zhao F; Zhang W; Xia W; Chen Y; Liu Y; Fan Z; Zhang Y; Yang Y
    Food Funct; 2022 Jan; 13(2):725-736. PubMed ID: 34935837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a mouse Lactobacillus johnsonii strain with deconjugase activity against the FXR antagonist T-β-MCA.
    DiMarzio M; Rusconi B; Yennawar NH; Eppinger M; Patterson AD; Dudley EG
    PLoS One; 2017; 12(9):e0183564. PubMed ID: 28910295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-lowering effects of taurine through the reduction of ileal FXR signaling due to the alteration of ileal bile acid composition.
    Miyata M; Tanaka T; Takahashi K; Funaki A; Sugiura Y
    Amino Acids; 2021 Oct; 53(10):1523-1532. PubMed ID: 34596761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol lowering in diet-induced hypercholesterolemic mice using
    Zhao M; Kuang W; Yang J; Liu Y; Yang M; Chen Y; Zhu H; Yang Y
    Food Funct; 2024 Feb; 15(3):1340-1354. PubMed ID: 38205623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism.
    Huang F; Zheng X; Ma X; Jiang R; Zhou W; Zhou S; Zhang Y; Lei S; Wang S; Kuang J; Han X; Wei M; You Y; Li M; Li Y; Liang D; Liu J; Chen T; Yan C; Wei R; Rajani C; Shen C; Xie G; Bian Z; Li H; Zhao A; Jia W
    Nat Commun; 2019 Oct; 10(1):4971. PubMed ID: 31672964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol-lowering potentials of Lactobacillus strain overexpression of bile salt hydrolase on high cholesterol diet-induced hypercholesterolemic mice.
    Wang G; Huang W; Xia Y; Xiong Z; Ai L
    Food Funct; 2019 Mar; 10(3):1684-1695. PubMed ID: 30839966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario.
    Choi SB; Lew LC; Yeo SK; Nair Parvathy S; Liong MT
    Crit Rev Biotechnol; 2015; 35(3):392-401. PubMed ID: 24575869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice.
    Hui S; Liu Y; Chen M; Wang X; Lang H; Zhou M; Yi L; Mi M
    Mol Nutr Food Res; 2019 Dec; 63(23):e1900608. PubMed ID: 31539192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.
    Gonzalez FJ; Jiang C; Patterson AD
    Gastroenterology; 2016 Nov; 151(5):845-859. PubMed ID: 27639801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysimachia christinae polysaccharide attenuates diet-induced hyperlipidemia via modulating gut microbes-mediated FXR-FGF15 signaling pathway.
    Zhou YF; Nie J; Shi C; Zheng WW; Ning K; Kang J; Sun JX; Cong X; Xie Q; Xiang H
    Int J Biol Macromol; 2023 Sep; 248():125725. PubMed ID: 37419267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile Salt Hydrolase and S-Layer Protein are the Key Factors Affecting the Hypocholesterolemic Activity of Lactobacillus casei-Fermented Milk in Hamsters.
    Guo CF; Zhang S; Yuan YH; Li JY; Yue TL
    Mol Nutr Food Res; 2018 Dec; 62(24):e1800728. PubMed ID: 30346664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.
    Xie C; Jiang C; Shi J; Gao X; Sun D; Sun L; Wang T; Takahashi S; Anitha M; Krausz KW; Patterson AD; Gonzalez FJ
    Diabetes; 2017 Mar; 66(3):613-626. PubMed ID: 28223344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diosgenin alleviates hypercholesterolemia via SRB1/CES-1/CYP7A1/FXR pathway in high-fat diet-fed rats.
    Yu L; Lu H; Yang X; Li R; Shi J; Yu Y; Ma C; Sun F; Zhang S; Zhang F
    Toxicol Appl Pharmacol; 2021 Feb; 412():115388. PubMed ID: 33383043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis.
    Ovadia C; Perdones-Montero A; Spagou K; Smith A; Sarafian MH; Gomez-Romero M; Bellafante E; Clarke LCD; Sadiq F; Nikolova V; Mitchell A; Dixon PH; Santa-Pinter N; Wahlström A; Abu-Hayyeh S; Walters JRF; Marschall HU; Holmes E; Marchesi JR; Williamson C
    Hepatology; 2019 Jul; 70(1):276-293. PubMed ID: 30983011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.
    Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Morretta E; Monti MC; Distrutti E; Fiorucci S
    FASEB J; 2022 Jan; 36(1):e22060. PubMed ID: 34862975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.
    Zhang Z; Du Z; Liu Q; Wu T; Tang Q; Zhang J; Huang C; Huang Y; Li R; Li Y; Zhao Y; Zhang G; Zhou J; Huang H; Fang Z; He J
    Metabolism; 2021 May; 118():154728. PubMed ID: 33581130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between gut bacteria and bile in health and disease.
    Long SL; Gahan CGM; Joyce SA
    Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.
    de Boer JF; Schonewille M; Boesjes M; Wolters H; Bloks VW; Bos T; van Dijk TH; Jurdzinski A; Boverhof R; Wolters JC; Kuivenhoven JA; van Deursen JM; Oude Elferink RPJ; Moschetta A; Kremoser C; Verkade HJ; Kuipers F; Groen AK
    Gastroenterology; 2017 Apr; 152(5):1126-1138.e6. PubMed ID: 28065787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The
    O'Flaherty S; Briner Crawley A; Theriot CM; Barrangou R
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29848760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.